Petros Pharmaceuticals, Inc. (PTPI) SEC Filings — 2025
18 SEC filings for Petros Pharmaceuticals, Inc. (PTPI) in 2025.
Filings
- Petros Pharma Swings to Profit on Asset Sales, Shifts to OTC Tech — 10-Q · Nov 13, 2025
- Petros Pharmaceuticals Faces Delisting Notice — 8-K · Nov 7, 2025
- Petros Pharma Changes Auditors to Marcum LLP — 8-K · Sep 5, 2025
- Petros Pharma Pivots to OTC Tech, Posts Q2 Profit on Asset Sales — 10-Q · Aug 14, 2025
- Petros Pharmaceuticals Files 8-K — 8-K · Jun 20, 2025
- Petros Pharma Faces Delisting Concerns — 8-K · May 21, 2025
- Petros Pharma 10-Q: Warrant Fair Value Inputs Detailed — 10-Q · May 15, 2025
- Petros Pharmaceuticals Faces Delisting Concerns — 8-K · May 2, 2025
- Petros Pharma Faces Delisting Concerns, Files 8-K — 8-K · Apr 11, 2025
- Petros Pharmaceuticals Files 8-K on Accountant Change — 8-K · Apr 9, 2025
- Petros Pharmaceuticals Files 2024 Annual Report — 10-K · Mar 31, 2025
- Petros Pharma Files Definitive Proxy Statement — DEF 14A · Mar 18, 2025
- Petros Pharmaceuticals Files 8-K — 8-K · Feb 21, 2025
- Petros Pharmaceuticals Files S-1/A Amendment — S-1/A · Feb 14, 2025
- Petros Pharma Files S-1/A Amendment — S-1/A · Feb 13, 2025
- Petros Pharma Files S-1/A Amendment — S-1/A · Feb 10, 2025
- Petros Pharma Files 8-K on Material Agreements — 8-K · Jan 24, 2025
- Petros Pharmaceuticals Files S-1 with SEC — S-1 · Jan 24, 2025